Cargando…

Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015

BACKGROUND: The diagnosis of neuroendocrine neoplasms (NENs) is often delayed. This first UK population-based epidemiological study of NENs compares outcomes with non-NENs to identify any inequalities. METHODS: Age-standardised incidence rate (ASR), 1-year overall survival, hazard ratios and standar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genus, Tracey S. E., Bouvier, Catherine, Wong, Kwok F., Srirajaskanthan, Rajaventhan, Rous, Brian A., Talbot, Denis C., Valle, Juan W., Khan, Mohid, Pearce, Neil, Elshafie, Mona, Reed, Nicholas S., Morgan, Eileen, Deas, Andrew, White, Ceri, Huws, Dyfed, Ramage, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889414/ https://www.ncbi.nlm.nih.gov/pubmed/31649320 http://dx.doi.org/10.1038/s41416-019-0606-3

Ejemplares similares

Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England
por: Russell, Beth, et al.
Publicado: (2023)

Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
por: White, Benjamin E., et al.
Publicado: (2022)

A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
por: Basuroy, Ron, et al.
Publicado: (2012)

Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
por: White, Benjamin E., et al.
Publicado: (2023)

Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2023)

Nutritional and vitamin status in patients with neuroendocrine neoplasms
por: Clement, Dominique SVM, et al.
Publicado: (2019)

Delays and routes to diagnosis of neuroendocrine tumours
por: Basuroy, Ron, et al.
Publicado: (2018)

ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2013)

The role of serotonin inhibition within the treatment of carcinoid syndrome
por: George, Joel, et al.
Publicado: (2023)

Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry
por: Palmer, Kieran, et al.
Publicado: (2022)

Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours
por: Clement, Dominique S. V. M., et al.
Publicado: (2023)

Posterior reversible encephalopathy syndrome in a patient with a metastatic pancreatic neuroendocrine tumour and ectopic Cushing’s syndrome
por: Palmer, Kieran, et al.
Publicado: (2021)

Feasibility of Home Parenteral Nutrition in Patients with Intestinal Failure Due to Neuroendocrine Tumours: A Systematic Review
por: Clement, Dominique S. V. M., et al.
Publicado: (2023)

Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis
por: Llewellyn, David C, et al.
Publicado: (2021)

Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study
por: Mandair, Dalvinder, et al.
Publicado: (2022)

Mesenteric Variceal Haemorrhage and Ectopic Cushing's Syndrome as Presenting Features of a Pancreatic Neuroendocrine Tumour Recurrence
por: Weerasuriya, Scott, et al.
Publicado: (2021)

Efficacy and safety of (177)Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
por: Clement, Dominique, et al.
Publicado: (2022)

Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review
por: Watson, Catherine, et al.
Publicado: (2020)

The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015
por: Brown, Katrina F., et al.
Publicado: (2018)

Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres
por: Frizziero, Melissa, et al.
Publicado: (2019)

Evaluating cost-effectiveness in the management of neuroendocrine neoplasms
por: White, B. E., et al.
Publicado: (2020)

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment
por: Doornebal, Ewald Jan, et al.
Publicado: (2022)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
por: Cope, Jack, et al.
Publicado: (2022)

Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome
por: Clement, Dominique, et al.
Publicado: (2020)

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with (177)Lu-DOTATATE
por: Strosberg, Jonathan R., et al.
Publicado: (2021)

Patient Survey of the Physical, Emotional, and Informational Challenges for Patients Living with Neuroendocrine Tumors
por: Khan, Mohid S., et al.
Publicado: (2019)

Impact of case management by advanced practice nurses in primary care on unplanned hospital admissions: a controlled intervention study
por: Huws, Dyfed W, et al.
Publicado: (2008)

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review
por: Khan, Mohid S, et al.
Publicado: (2020)

Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
por: Li, Su-Chen, et al.
Publicado: (2015)

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours
por: Mills, Logan, et al.
Publicado: (2017)

Matching-adjusted indirect treatment comparison of [(177)Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [(177)Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
por: Khan, Mohid S., et al.
Publicado: (2021)

Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
por: Ramage, John K., et al.
Publicado: (2022)

The Impact of (68)Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review
por: Cella, David, et al.
Publicado: (2021)

Evaluation of a national lung cancer symptom awareness campaign in Wales
por: McCutchan, Grace, et al.
Publicado: (2019)

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012
por: Ward, Derek J, et al.
Publicado: (2014)

Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer
por: Lüchtenborg, Margreet, et al.
Publicado: (2018)

The Role of Patient Support Groups in Neuroendocrine Neoplasms
por: Kolarova, Teodora, et al.
Publicado: (2021)

Using population-scale medication data to evaluate the impact of the COVID-19 pandemic on the usage of analgesics by cancer patients.
por: Han, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lqa9ta4g42o8ikh3318oehauu9